These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9629417)

  • 1. [Neuroimage findings in hepatocerebral degeneration induced by hemochromatosis].
    Werneck AL; Gdalevici C; Fonseca RI
    Arq Neuropsiquiatr; 1997 Sep; 55(3B):625-31. PubMed ID: 9629417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic acquired hepatocerebral degeneration: case reports and new insights.
    Jog MS; Lang AE
    Mov Disord; 1995 Nov; 10(6):714-22. PubMed ID: 8749990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired hepatocerebral degeneration: MR similarity with Wilson disease.
    Hanner JS; Li KC; Davis GL
    J Comput Assist Tomogr; 1988; 12(6):1076-7. PubMed ID: 3183119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic encephalopathy coexists with acquired chronic hepatocerebral degeneration.
    Huang FZ; Hou X; Zhou TQ; Chen S
    Neurosciences (Riyadh); 2015 Jul; 20(3):277-9. PubMed ID: 26166598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal intensity loss on T2-weighted gradient-recalled echo magnetic resonance images in the basal ganglia in a patient with chronic hepatic encephalopathy.
    Dharmasaroja P
    Neurologist; 2010 Jul; 16(4):265-8. PubMed ID: 20592571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of acute cytotoxic changes in progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome) using diffusion-weighted MRI and MR spectroscopy.
    Ulmer S; Flemming K; Hahn A; Stephani U; Jansen O
    J Comput Assist Tomogr; 2002; 26(4):641-6. PubMed ID: 12218835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired (non-Wilsonian) hepatocerebral degeneration.
    Khan FS; Ashalatha R
    Neurol India; 2004 Dec; 52(4):527. PubMed ID: 15626867
    [No Abstract]   [Full Text] [Related]  

  • 8. Case of pediatric acquired chronic hepatocerebral degeneration.
    Papapetropoulos S; Tzakis A; Sengun C; Reddy C; Boukas K; Zitser J; Singer C
    Pediatr Neurol; 2008 Jan; 38(1):67-70. PubMed ID: 18054700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired hepatocerebral degeneration.
    Yalcin D; Oguz-Akarsu E; Sokmen M
    Neurosciences (Riyadh); 2016 Apr; 21(2):164-7. PubMed ID: 27094529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puzzles in practice: acquired hepatocerebral (or hepatolenticular) degeneration (AHD).
    Mishriki YY
    Postgrad Med; 2014 Nov; 126(7):160-3. PubMed ID: 25548817
    [No Abstract]   [Full Text] [Related]  

  • 11. Basal ganglia hyperintensity may be a marker of hepatic encephalopathy secondary to portosystemic shunting.
    Jiang M; Wang Z; Tsauo J; Li X
    Clin Res Hepatol Gastroenterol; 2015 Feb; 39(1):e5-6. PubMed ID: 25239699
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquired hepatocerebral degeneration: MR and pathologic findings.
    Lee J; Lacomis D; Comu S; Jacobsohn J; Kanal E
    AJNR Am J Neuroradiol; 1998 Mar; 19(3):485-7. PubMed ID: 9541303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical and radiological improvement of chronic acquired hepatocerebral degeneration after obliteration of portosystemic shunt: Report of a case.
    Hisahara S; Matsushita T; Kitamura M; Mezawa S; Nonaka M; Imai T; Shimohama S
    J Neurol Sci; 2014 Nov; 346(1-2):303-6. PubMed ID: 25172193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of trientine on manganese intoxication in a patient with acquired hepatocerebral degeneration.
    Park HK; Kim SM; Choi CG; Lee MC; Chung SJ
    Mov Disord; 2008 Apr; 23(5):768-70. PubMed ID: 18307260
    [No Abstract]   [Full Text] [Related]  

  • 15. Acquired hepatocerebral degeneration and hepatic encephalopathy: correlations and variety of clinical presentations in overt and subclinical liver disease.
    Romeiro FG; Américo MF; Yamashiro FS; Caramori CA; Schelp AO; Santos AC; Silva GF
    Arq Neuropsiquiatr; 2011 Jun; 69(3):496-501. PubMed ID: 21755129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Updates on Acquired Hepatocerebral Degeneration.
    Shin HW; Park HK
    Tremor Other Hyperkinet Mov (N Y); 2017; 7():463. PubMed ID: 28975044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebral MR imaging in patients with primary biliary cirrhosis].
    Uchino A; Hasuo K; Matsumoto S; Masuda K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Feb; 53(2):145-9. PubMed ID: 8488097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined orthotopic heart and liver transplantation for genetic hemochromatosis.
    Surakomol S; Olson LJ; Rastogi A; Steers JL; Sterioff S; Daly RC; McGregor CG
    J Heart Lung Transplant; 1997 May; 16(5):573-5. PubMed ID: 9171279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of hepatocellular carcinoma arising in genetic hemochromatosis.
    Lwakatare F; Hayashida Y; Yamashita Y
    Magn Reson Med Sci; 2003 Apr; 2(1):57-9. PubMed ID: 16210821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Special clinico-therapeutic aspects of chronic hepatic encephalopathy (chronic progressive hepatocerebral degeneration)].
    Constantinovici A; Drăghici L; Moldovan M; Răduţoiu E; Oşanu M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1984; 29(3):185-9. PubMed ID: 6239348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.